Invesco’s Tonix Pharmaceuticals TNXP Stock Holding History

Invesco’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$210K	Buy	+15,265	New	+$235K	﹤0.01%	3470
2022 Q2	–	Hold	0	–	-$32K	–	4144
2022 Q1	–	Hold	0	–	–	–	3962
2021 Q4	–	Hold	0	–	–	–	3996
2021 Q3	–	Hold	0	–	–	–	3985
2021 Q2	–	Hold	0	–	–	–	3899
2015 Q1	–	Hold	0	–	-$62K	–	4069
2014 Q4	–	Hold	0	–	–	–	3888

Other funds holding TNXP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco's TNXP Position: Q1 2026 in Review

Invesco opened a new position in Tonix Pharmaceuticals (TNXP) in Q1 2026: 15,265 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #3470 among its holdings.

81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

Invesco held 15,265 shares of Tonix Pharmaceuticals worth $210K as of Q1 2026.
Tonix Pharmaceuticals was a new Invesco position in Q1 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3470 holding.
81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.